662 / 1173
1/03/2016
1
Biological response modifiers
Clinical
Karin Haustermans
Department of Radiation Oncology, University Hospitals Leuven,
Belgium
1
Overview
•
Introduction
•
Target driven lethality
•
EGFR inhibitors
•
Synthetic lethality
•
DNA-repair inhibitors
•
Contextual lethality
•
VEGF inhibitors
•
Vascular disrupting agents
•
Immune activation
•
Take home messages
2
Chapter 21
M Baumann & V Grégoire